Provectus Biopharmaceuticals, Inc. Reports First Quarter 2016 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. CMG
7. TENB
8. BIIB
9. KLAC
10. ETSY

Go back to Provectus Biopharmaceuticals, Inc. Reports First Quarter 2016 Financial Results

Provectus Biopharma (PVCT) Reports Q1 Loss of $0.04/Share

May 11, 2016 6:30 AM EDT

Provectus Biopharma (NYSE: PVCT) reported Q1 EPS of ($0.04), versus ($0.02) reported last year.

Provectus noted the following balance sheet highlights:

Our cash and cash equivalents were $9,760,997 at March 31, 2016, compared with $14,178,902 at December 31, 2015. The decrease of approximately $4.4 million was due primarily to the... More